120 related articles for article (PubMed ID: 8625252)
1. Disseminated neuroblastoma in the nude rat. A xenograft model of human malignancy.
Martinez DA; Kahwash S; O'Dorisio MS; Lloyd TV; McGhee RB; Qualman SJ
Cancer; 1996 Jan; 77(2):409-19. PubMed ID: 8625252
[TBL] [Abstract][Full Text] [Related]
2. Inverse expressions of the N-myc oncogene and beta 1 integrin in human neuroblastoma: relationships to disease progression in a nude mouse model system.
Judware R; Lechner R; Culp LA
Clin Exp Metastasis; 1995 Mar; 13(2):123-33. PubMed ID: 7533687
[TBL] [Abstract][Full Text] [Related]
3. Integrin expression in human neuroblastoma cells with or without N-myc amplification and in ectopic/orthotopic nude mouse tumors.
Flickinger KS; Judware R; Lechner R; Carter WG; Culp LA
Exp Cell Res; 1994 Jul; 213(1):156-63. PubMed ID: 8020586
[TBL] [Abstract][Full Text] [Related]
4. Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse.
Ferrandis E; Da Silva J; Riou G; Bénard I
Cancer Res; 1994 Apr; 54(8):2256-61. PubMed ID: 8174136
[TBL] [Abstract][Full Text] [Related]
5. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
[TBL] [Abstract][Full Text] [Related]
6. [Establishing a new human neuroblastoma animal model for development of adjuvant therapy methods and for study of metastasis].
Engler S; Thiel C; David K; Juhl H
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):285-8. PubMed ID: 14518261
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of transfected N-myc oncogene in human SKNSH neuroblastoma cells down-regulates expression of beta 1 integrin subunit.
Judware R; Culp LA
Oncogene; 1995 Dec; 11(12):2599-607. PubMed ID: 8545117
[TBL] [Abstract][Full Text] [Related]
8. A metastatic neuroblastoma model in SCID mice.
Bogenmann E
Int J Cancer; 1996 Jul; 67(3):379-85. PubMed ID: 8707412
[TBL] [Abstract][Full Text] [Related]
9. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Kennett RH; Rosen ST; DiGiuseppe JA; Brodeur GM
Oncogene; 1990 Dec; 5(12):1821-7. PubMed ID: 2284101
[TBL] [Abstract][Full Text] [Related]
10. S-cells from a highly N-myc-amplified neuroblastoma are tumorigenic in nude mice.
Sleight BJ; Soukup S; Ballard ET; Parysek LM
Anticancer Res; 1993; 13(6A):2031-6. PubMed ID: 8297111
[TBL] [Abstract][Full Text] [Related]
11. Human neuroblastoma in nude mice.
Helson L; Das SK; Hajdu SI
Cancer Res; 1975 Sep; 35(9):2594-9. PubMed ID: 167965
[TBL] [Abstract][Full Text] [Related]
12. A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies.
Engler S; Thiel C; Förster K; David K; Bredehorst R; Juhl H
Cancer Res; 2001 Apr; 61(7):2968-73. PubMed ID: 11306475
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptor gene expression in neuroblastoma.
Albers AR; O'Dorisio MS; Balster DA; Caprara M; Gosh P; Chen F; Hoeger C; Rivier J; Wenger GD; O'Dorisio TM; Qualman SJ
Regul Pept; 2000 Mar; 88(1-3):61-73. PubMed ID: 10706954
[TBL] [Abstract][Full Text] [Related]
14. In vivo echographic evidence of tumoral vascularization and microenvironment interactions in metastatic orthotopic human neuroblastoma xenografts.
Joseph JM; Gross N; Lassau N; Rouffiac V; Opolon P; Laudani L; Auderset K; Geay JF; Mühlethaler-Mottet A; Vassal G
Int J Cancer; 2005 Mar; 113(6):881-90. PubMed ID: 15514941
[TBL] [Abstract][Full Text] [Related]
15. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines.
Sivak LE; Tai KF; Smith RS; Dillon PA; Brodeur GM; Carroll WL
Oncogene; 1997 Oct; 15(16):1937-46. PubMed ID: 9365240
[TBL] [Abstract][Full Text] [Related]
16. Description of a new xenograft model of metastatic neuroblastoma using NOD/SCID/Il2rg null (NSG) mice.
Sartelet H; Durrieu L; Fontaine F; Nyalendo C; Haddad E
In Vivo; 2012; 26(1):19-29. PubMed ID: 22210712
[TBL] [Abstract][Full Text] [Related]
17. [N-myc gene copies in children with neuroblastoma and its clinical significance].
Ma XL; Gong LP; Zhou CJ; Zhang DW; Jin M; Wang HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1447-51. PubMed ID: 23257451
[TBL] [Abstract][Full Text] [Related]
18. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
[TBL] [Abstract][Full Text] [Related]
19. Molecular therapy of human neuroblastoma cells using Auger electrons of 111In-labeled N-myc antisense oligonucleotides.
Watanabe N; Sawai H; Ogihara-Umeda I; Tanada S; Kim EE; Yonekura Y; Sasaki Y
J Nucl Med; 2006 Oct; 47(10):1670-7. PubMed ID: 17015904
[TBL] [Abstract][Full Text] [Related]
20. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
Spengler BA; Lazarova DL; Ross RA; Biedler JL
Oncol Res; 1997; 9(9):467-76. PubMed ID: 9495452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]